Persistent Asthma

Persistent Asthma

Dec 07, 2017 01:57 PM EDT - Author: Amber

 

Are you suffering from Asthma? If you are taking a combination inhaler (such as Breo, Symbicort, Dulera, Advair, etc.). You may qualify for a clinical trial that is seeking people who have persistent Asthma.

       PERSISTENT ASTHMA

  • Asthma symptoms more than twice a week, but not every day.
  • Daily activity is slightly limited due to asthma symptoms.
  • Wake up occasionally because of symptoms.
  • Use rescue medications more than twice a week to control their asthma symptoms, but not daily.

This study will last about 6 months and will include 10 office visits. All visits are conducted locally in Salt Lake City, Utah.

Benefits of Participating:

  • Receive compensation up to $1,500.00 for time and travel
  • Study medications and Albuterol provided.
  • No cost to participate.
  • No insurance needed.
  • Completely voluntary, no obligation to continue.

To Qualify, You Must:

  • Be between 18 and 80 years old.
  • Be diagnosed with Asthma.
  • Be taking a combination inhaler such as Symbicort, Breo, Ellipta, Advair, AirDuo, RespiClick, or Dulera for Asthma consistently.

To find out more call us at 801-363-7353 or submit the form below. By contacting us, you are in no way obligated to participate.  All information submitted is kept strictly confidential and is never shared or sold to third parties.

 

 


Get Involved!
First Name: *
Last Name: *
Email: *
Phone:
Age:
What studies would you be interested in participating in? (Select all that apply)

Arthritis

Diabetes Type 2

High Blood Pressure

Asthma

Gout

High Cholesterol

COPD/Emphysema

Heart Attack

Stroke

Diabetes Type 1

Heart Disease

Weight Loss

Acne

Migraine

Low Testosterone

Osteoarthritis

We’re always adding new studies to our list, what other conditions do you have or would you be interested in joining a study for? (I.E. Fibromyalgia, etc.)
Medications you currently take (Optional):
How Did You Hear About Us?

Subscribe to OCR's Monthly Newsletter
 
;